Abstract

Delineating the nanoscale properties and the dynamic assembly and disassembly behaviors of amyloid fibrils is key for technological applications that use the material properties of amyloid fibrils, as well as for developing treatments of amyloid-associated disease. However, quantitative mechanistic understanding of the complex processes involving these heterogeneous supramolecular systems presents challenges that have yet to be resolved. Here, we develop an approach that is capable of resolving the time dependence of fibril particle concentration, length distribution, and length and position dependence of fibril fragmentation rates using a generic mathematical framework combined with experimental data derived from atomic force microscopy analysis of fibril length distributions. By application to amyloid assembly of β2-microglobulin in vitro under constant mechanical stirring, we present a full description of the fibril fragmentation and growth behavior, and demonstrate the predictive power of the approach in terms of the samples’ fibril dimensions, fibril load, and their efficiency to seed the growth of new amyloid fibrils. The approach developed offers opportunities to determine, quantify, and predict the course and the consequences of amyloid assembly.

Highlights

  • Amyloid fibrils represent a class of supramolecular particles self-assembled from a variety of naturally occurring or designed proteins or peptide sequences [1,2,3,4,5]

  • The recognition that fibril fragmentation produces particles that may have new biological properties has increased excitement in our quest to understand the mechanical properties of amyloid fibrils and their fragmentation processes [3,12,32,40]

  • We have determined the molar fibril particle concentration and revealed how the rate of fibril fragmentation varies as a function of fibril length and breakage position

Read more

Summary

Introduction

Amyloid fibrils represent a class of supramolecular particles self-assembled from a variety of naturally occurring or designed proteins or peptide sequences [1,2,3,4,5]. These nanostructures are associated with numerous devastating human disorders, such as type II diabetes mellitus, Alzheimer’s and Parkinson’s diseases [1]. Despite these assemblies being linked to disease, amyloid fibril nanostructures have favorable molecular and material properties that could be harnessed for technological applications.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call